Clinical genome sequencing now delivers genetic diagnoses for about 1 in 4 suspected rare disease patients, guiding targeted ...

A landmark study harnesses long-read sequencing to reveal vast, previously undetected structural variations in human DNA, reshaping our understanding of genetics and disease potential. Study: ...

Researchers from Children's Hospital of Philadelphia (CHOP) developed a new RNA sequencing strategy that can reveal how genetic variants disrupt gene function and improve the diagnosis of rare ...

A new research paper was published in Oncotarget's Volume 15 on February 5, 2024, entitled, "Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas: next-generation sequencing and ...

One in every 10 people worldwide is impacted by a rare genetic disease but about 50% of them remain undiagnosed despite rapid increases in genetic technology and testing. Even when a person does have ...

Explore the decades-long journey to map the full human genome, from early breakthroughs to the first complete, gapless DNA ...

The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...

A Boston-based genomics firm co-founded by a Harvard Medical School professor has launched what it calls the world’s first whole-genome sequencing service for under $1,000 — $999 to be precise. For ...

FREMONT, Calif., March 19, 2026 /PRNewswire/ -- Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, today announced that Basecamp Research, a frontier AI lab for ...

It's time to ditch the one-size-fits-all approach in medicine. From cancer care and cardiology to TB and rare disorders, DNA ...